Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL

por Li, Mingqing, Kim, William Y
Publicado 2011

Molecular responses to hypoxia: ancient pathways, clinical promises

por Kim, William Y, Ivan, Mircea
Publicado en J Cell Mol Med (2009)

Drug Efficacy Testing in Mice

por Kim, William Y., Sharpless, Norman E.
Publicado 2012

Stearoyl Co-A Desaturase 1 as a ccRCC Therapeutic Target: Death by Stress

por Leung, Janet Y., Kim, William Y.
Publicado 2013

The next steps in next-gen sequencing of cancer genomes

por Hayes, D. Neil, Kim, William Y.
Publicado en J Clin Invest (2015)

Bap1 and Pbrm1: Determinants of Tumor Grade and mTOR Activation in VHL-Deficient Mouse Models of Renal Cell Carcinoma

por Leung, Janet Y., Kim, William Y.
Publicado en Cancer Discov (2017)

Systemic Delivery of Gemcitabine Triphosphate via LCP Nanoparticles for NSCLC and Pancreatic Cancer Therapy

por Zhang, Yuan, Kim, William Y, Huang, Leaf
Publicado 2013

HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer

por Jackson, Autumn L, Zhou, Bing, Kim, William Y
Publicado 2010

Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies GRIA1 as a prognostic biomarker for basal-like bladder cancer

por Tilley, Sloane K, Kim, William Y, Fry, Rebecca C
Publicado en Am J Cancer Res (2017)

Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth

por Kondo, Keiichi, Kim, William Y, Lechpammer, Mirna, Kaelin, William G
Publicado 2003

Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer

por Miao, Lei, Guo, Shutao, Zhang, Jing, Kim, William Y., Huang, Leaf
Publicado en Adv Funct Mater (2014)

Codelivery of VEGF siRNA and Gemcitabine Monophosphate in a Single Nanoparticle Formulation for Effective Treatment of NSCLC

por Zhang, Yuan, Schwerbrock, Nicole MJ, Rogers, Arlin B, Kim, William Y, Huang, Leaf
Publicado 2013

Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell Carcinoma

por Bhavani, Krishnan, Tracy L., Rose, Kardos, Jordan, Milowsky, Matthew I., Kim, William Y.
Publicado en JAMA Oncol (2016)

Age at Diagnosis, Obesity, Smoking, and Molecular Subtypes in Muscle Invasive Bladder Cancer

por Sun, Xuezheng, Hoadley, Katherine A., Kim, William Y., Furberg, Helena, Olshan, Andrew F., Troester, Melissa A.
Publicado en Cancer Causes Control (2017)

Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model

por Zhang, Jing, Miao, Lei, Guo, Shutao, Zhang, Yuan, Zhang, Lu, Satterlee, Andrew, Kim, William Y., Huang, Leaf
Publicado 2014

An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells

por Ohh, Michael, Kim, William Y., Moslehi, Javid J., Chen, Yuzhi, Chau, Vincent, Read, Margaret A., Kaelin, William G.
Publicado 2002

Nanoparticle Modulation of the Tumor Microenvironment Enhances Therapeutic Efficacy of Cisplatin

por Miao, Lei, Wang, Yuhua, Xiong, Yang, Lin, C. Michael, Chen, Naihan, Zhang, Lu, Kim, William Y., Huang, Leaf
Publicado en J Control Release (2015)

Racial disparities in survival in advanced renal cell carcinoma in the targeted therapy era

por Rose, Tracy L., Deal, Allison M., Krishnan, Bhavani, Nielsen, Matthew E., Smith, Angela B., Kim, William Y., Milowsky, Matthew I.
Publicado en Cancer (2016)

Failure to prolyl hydroxylate hypoxia-inducible factor α phenocopies VHL inactivation in vivo

por Kim, William Y, Safran, Michal, Buckley, Marshall R M, Ebert, Benjamin L, Glickman, Jonathan, Bosenberg, Marcus, Regan, Meredith, Kaelin, William G
Publicado 2006

Sav1 Loss Induces Senescence and Stat3 Activation Coinciding with Tubulointerstitial Fibrosis

por Leung, Janet Y., Wilson, Harper L., Voltzke, Kristin J., Williams, Lindsay A., Lee, Hyo Jin, Wobker, Sara E., Kim, William Y.
Publicado en Mol Cell Biol (2017)